Chexx Inc.’s proven payment disbursement solutions are a powerful tool in strengthening patient relationships in markets around the globe.
Vancouver, BC (PRWEB) June 20, 2013
Chexx Inc., a company that specializes in issuing and sending stipend payments to clinical trial patients around the world, announced today that they will be exhibiting at the DIA 49th Annual Meeting, June 24-26, 2013 in Boston. DIA 2013 will provide an invaluable forum for professionals involved in the discovery, development, and life-cycle management of pharmaceuticals, medical devices, and related products. The event will also include discussion of current and evolving areas such as comparative effectiveness research, health outcomes, and drug/device combination products. As a key international payments provider in the clinical trial space, Chexx Inc. will be on the floor at booth 747, arming attendees with information on how proper payment method plays a role in developing strong relationships with clinical trial participants, increasing goodwill and patient retention.
Chexx Inc. enables research companies to send real-money stipends by international check, EFT or preloaded credit cards in virtually every corner of the globe. “Chexx Inc.’s proven payment disbursement solutions are a powerful tool in strengthening patient relationships in markets around the globe,” says Peter Sampson, VP of Corporate Development for Chexx Inc., “We’re pleased to provide affordable payment options in emerging markets like India, Brazil, Mexico and Malaysia. Sponsors and CROs who want to give their participants the luxury of choice will want to learn about QuickDraw, which allows patients to decide how and where they will be paid.”
The Annual Meeting is intended to strengthen professionals’ understanding of the value of cross-discipline integration and to foster innovation for better health outcomes. Attendees will join more than 7,000 life sciences professionals at all levels and across all disciplines involved in the discovery, development, and life cycle management of medical products all with a common goal to foster innovation that will lead to the development of safe and effective medical products and therapies to patients.
About Chexx Inc.:
Chexx Inc. serves the payment disbursement needs of clinical trial companies, market research companies, international payroll, sales organizations and affiliate managers around the world. For over 17 years they have specialized in providing timely, convenient and cost-effective payouts with excellent results. Chexx Inc. maintains a large network of regional banks to provide payment coverage in over 200 countries. Considerable resources are focused on technical integration and relationship management with each banking partner, resulting in stable global coverage and built in redundancy in key regions.